TGFB1 and idiopathic pulmonary fibrosis: Recent studies demonstrated that the roles of inflammatory cells are less critical than the therapeutic effect of TGF‐β1 signalling inhibition,11, 12 promoting continuous efforts to develop new TGF‐β signalling inhibitors for treating patients with IPF.